Blog

Pharmacogenomic Testing (GeneSight) in Residential Mental Health: How It Guides Medication Selection
NewsHow pharmacogenomic testing like GeneSight and Genomind is used inside a residential mental health program to guide psychiatric medication selection — who benefits, what the report actually says, and what the test cannot do.

Transcranial Magnetic Stimulation (TMS) in Residential Mental Health Treatment: How Neuromodulation Integrates Into a 30-Day Program
NewsHow Bodhi Mental Health integrates TMS (rTMS and accelerated protocols like SAINT) into a 30-day residential program for treatment-resistant depression, OCD, and comorbid anxiety.

Neurofeedback in Residential Mental Health Treatment: A Clinical Guide for Executives and Professionals
NewsHow boutique residential mental health programs use qEEG-guided neurofeedback alongside TMS, brainspotting, and pharmacogenomic testing to restore executive function and emotional regulation in 30 days.

Brainspotting Therapy in Residential Mental Health Treatment: A Clinical Guide to Processing Complex Trauma and PTSD
NewsFor adults whose complex trauma has not fully resolved through years of talk therapy, EMDR, or medication trials, Brainspotting often becomes the modality that finally reaches the material the cortex has been unable to language. In a residential…

Residential Mental Health Treatment for Physicians Under FSPHP Monitoring: A Confidential Track for Executives and Medical Professionals
NewsA residential mental health program built for physicians and licensed professionals under FSPHP monitoring: 6-to-12-bed census, 24/7 nursing, pharmacogenomic testing, TMS, brainspotting, and forensic-grade documentation coordinated with your state PHP.

How TMS Therapy Works During a 30-Day Residential Mental Health Program for Treatment-Resistant Depression
NewsIntroduction
When major depression fails to respond to two or more adequate trials of antidepressant medication, the clinical designation shifts to treatment-resistant depression (TRD). For adults living with TRD, a 30-day residential mental…

GeneSight vs Genomind for Treatment-Resistant Depression: What Residential Mental Health Programs Actually Use
NewsGeneSight and Genomind both use CYP450 pharmacogenomic data — but they differ in gene panel, format, insurance, and timing. How Bodhi chooses between the two.

How DBT Works in Residential Mental Health Treatment: A Clinical Guide to Skills, Sessions, and Emotional Regulation
NewsDialectical behavior therapy delivered inside residential mental health treatment compresses a year of outpatient skills work into weeks. Here is how DBT modules, individual sessions, and milieu coaching combine to stabilize severe emotional dysregulation, self-harm urges, and treatment-resistant depression.

How Families Participate in Residential Mental Health Treatment for an Adult Child
NewsA clinical guide to how families participate in residential mental health treatment for an adult child — what helps, what to avoid, and how to stay involved.

Residential Treatment for Postpartum Depression: When Inpatient Care Saves Lives
NewsResidential treatment for postpartum depression provides 24/7 psychiatric care for severe symptoms when outpatient support is no longer enough for healing.

Complex Trauma and Residential Mental Health Care: A Path Toward Lasting Healing
NewsComplex trauma rarely resolves with weekly therapy alone. Learn how residential mental health care supports lasting healing through evidence-based modalities.

The Role of Medication Management in Residential Mental Health Treatment
NewsMedication management in residential mental health treatment: how psychiatric oversight, monitoring, and therapy work together for severe conditions.

